Congenital syphilis (CS) is increasing in the U.S., largely due to pregnant women with untreated syphilis, leading to severe complications like stillbirth and developmental issues in infants.
Preventing CS involves early identification and treatment of infected pregnant women with benzathine penicillin G at least 30 days before delivery.
The article highlights public health challenges in addressing CS, identifies missed prevention opportunities, and suggests practical solutions for future strategies.